MedTrace Logo

Changes in Electroretinogram and Contrast Sensitivity After PASCAL Treatment

NCT00563043 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-05-30

No results posted yet for this study

Summary

Laser photocoagulation has become the treatment of choice in PDR. Laser photocoagulation has become the treatment of choice in PDR. The aim is to destroy a substantial portion of the peripheral retina in order to reduce the angiogenic stimulus (decrease the difference between oxygen demand and the administration). Their effectiveness is determined by the extent of destruction of the retina (2.4).

Conditions

  • Non Proliferative Diabetic Retinopathy
  • Proliferative Diabetic Retinopathy

Interventions

PROCEDURE

PASCAL laser treatment

Patterns Scan Laser treatment in patients with PDR.

Sponsors & Collaborators

  • Asociación para Evitar la Ceguera en México

    lead OTHER

Principal Investigators

  • Raul Velez-Montoya, MD · Asociaciòn para Evitar la Ceguera en Mèxico

  • Hugo Quiroz-Mercado, MD · Asociaciòn para Evitar la Ceguera en Mèxico

  • Virgilio Morales-Canton, MD · Asociaciòn para Evitar la Ceguera en Mèxico

  • Juan Manuel Jimenez-Sierra, MD · Asociaciòn para Evitar la Ceguera en Mèxico

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2007-10-31
Completion
2008-02-29

Countries

  • Mexico

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00563043 on ClinicalTrials.gov